26 results
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:56am
exposure to product liability or similar claims if the use of any of our products were to cause or contribute to injury or death. There is also
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:55am
or death. There is also the possibility that defects in the design or manufacture of any of our products might necessitate a product recall. Although we
POS AM
RAPH
Raphael Pharmaceutical Inc.
4 May 23
Prospectus update (post-effective amendment)
4:01pm
or death. There is also the possibility that defects in the design or manufacture of any of our products might necessitate a product recall. Although
POS AM
RAPH
Raphael Pharmaceutical Inc.
2 May 23
Prospectus update (post-effective amendment)
4:02pm
, and we face financial exposure to product liability or similar claims if the use of any of our products were to cause or contribute to injury or death
POS AM
7z5oyhzg68v
26 May 22
Prospectus update (post-effective amendment)
9:28am
10-12G/A
o2wa5ui n7
23 Sep 21
Registration of securities (amended)
6:19am
10-12G/A
rbbd84 a9smz
2 Sep 21
Registration of securities (amended)
5:28pm
10-12G
sh1q7pb42bkhet5
29 Jul 21
Registration of securities
12:00am
10-12G/A
hi6p1u5v20bp3672e6le
2 Jul 21
Registration of securities (amended)
4:15pm
10-12G
w1c 89eky8f
14 May 21
Registration of securities
5:27pm
10-K
ells6 030b1
27 Mar 09
Annual report
12:00am
424B3
t0qjen8p3qc1z7
4 Nov 08
Prospectus supplement
12:00am